ABL for Healthcare Receivables: Medicare, Medicaid, and Third-Party Payor Mechanics

Healthcare Receivables Are Not Commercial Receivables

An asset-based lender looking at a typical commercial AR pool sees an invoice for the contracted price, payable in thirty to sixty days, by a creditworthy buyer, against a known dilution rate of one to three percent. A lender looking at a healthcare receivable sees something fundamentally different: a charge billed at gross rates that the payor will adjust down by half or more, paid on a timeline driven by claim adjudication rather than commercial payment terms, against contractual allowances that often dwarf the cash collected. On top of that, the largest payors -- Medicare and Medicaid -- cannot legally be assigned to a lender at all.

None of that makes healthcare AR uneconomic to finance. It does mean that healthcare ABL is its own discipline, with its own borrowing base mechanics, its own collateral perfection workarounds, and its own short list of lenders who actually do the work. Borrowers who treat healthcare AR like commercial AR get declined or get advance rates that bear no relationship to the cash the receivables actually produce.

At Don Clarke Enterprises, we place ABL facilities for healthcare borrowers across the spectrum: hospitals, physician groups, surgery centers, diagnostic labs, home health agencies, behavioral health providers, and specialty pharmacies. Donald Clarke founded Asset Based Lending Consultants in 1986, was inducted into the SFNet Hall of Fame in 2021, and authored Asset Based Lending Disciplines -- the first textbook on the discipline. He has trained more than 5,000 lending professionals at institutions including GE Capital, JP Morgan Chase, Lloyds, and Barclays on the structures described in this article. We do not consult. We execute.

The Anti-Assignment Problem: Medicare and Medicaid

The single biggest legal constraint in healthcare ABL is that Medicare and Medicaid receivables cannot be assigned to a lender. Federal regulations -- specifically the Social Security Act and the implementing rules at 42 CFR Part 424 -- prohibit a Medicare provider from assigning the right to receive payment to anyone other than the beneficiary or the provider itself. State Medicaid programs operate under similar prohibitions. The practical effect is that a lender cannot take direct collateral assignment of these receivables and cannot legally direct the government payor to remit payment to a lender-controlled account.

For most middle-market healthcare borrowers, that is a serious problem, because Medicare and Medicaid often represent forty to seventy percent of the receivables pool. A lender that simply excludes those receivables from the borrowing base will produce an availability number that is unworkably small. The industry developed a structural workaround that allows lenders to advance against these receivables without taking a direct assignment.

The Lockbox and DACA Structure

The mechanics work like this. The borrower opens a deposit account in its own name -- a government-receivables lockbox -- into which all Medicare, Medicaid, and other government payments are deposited. The provider directs the government payors to remit payment to that account through ordinary enrollment and EFT setup. Title to the funds in the account belongs to the borrower at all times, which preserves the no-assignment rule.

The borrower then signs a deposit account control agreement, or DACA, with the depositary bank under UCC Section 9-104. The DACA gives the lender a perfected security interest in the deposit account itself -- not in the underlying receivable -- and contractual control rights over the account once the borrower deposits the funds. On a daily or weekly sweep cycle, funds in the lockbox are transferred to a commercial concentration account, and from there into the borrower\'s operating account or against the revolving credit balance.

The structure is well-tested and is how every serious healthcare ABL lender perfects against government receivables. It does add documentation complexity and cycle time at closing, because the depositary bank, the borrower, and the lender all have to execute the DACA, and the government payor enrollment changes can take thirty to ninety days to flow through. Borrowers who plan ahead can compress that timeline meaningfully.

Net Collectible Value: How Healthcare Borrowing Bases Actually Work

In commercial ABL, the borrowing base advance rate is applied to the face value of eligible invoices. In healthcare ABL, the lender advances against net collectible value -- which is dramatically lower than gross billings. A hospital might bill $100 of charges for a service that the commercial insurer pays $40 against, that Medicare pays $30 against, and that the patient ultimately pays $5 against. The borrowing base needs to reflect what will actually be collected, not what was billed.

Healthcare ABL lenders address this through a multi-step calculation. First, gross AR is reduced by contractual allowances -- the difference between billed charges and contracted reimbursement rates -- payor by payor. Next, the lender applies aging cutoffs, typically excluding receivables more than 120 or 150 days old. The lender then applies eligibility filters that exclude self-pay receivables, claims in dispute, claims pending denial appeal, claims with provider credentialing issues, and certain payor concentrations. The remaining net eligible AR is then subject to advance rates, which typically run sixty-five to eighty-five percent depending on the payor mix, the provider\'s historical collection performance, and the lender.

The discipline of converting gross AR into net collectible value is exactly the kind of work covered in our eligible vs. ineligible receivables guide. The healthcare-specific overlay is that the contractual allowance calculation is itself a major source of borrowing base variability, and lenders update the contractual allowance assumption based on actual collections data on a rolling basis.

Dilution in Healthcare AR

Dilution in commercial ABL typically runs one to four percent and reflects returns, allowances, and bad debt. Dilution in healthcare ABL is structurally different and structurally larger. It includes contractual adjustments (which the borrowing base already nets out), but also denials, takebacks, recoupments, retroactive payor audits, and Medicare or Medicaid recoupment of overpayments.

Lenders track healthcare dilution closely because it directly drives the advance rate and the dilution reserve. A provider with a 10 percent net dilution rate (after contractual allowances) is on the high side and will see advance rates near the bottom of the range. A provider with 3 to 5 percent net dilution is well-managed and will see advance rates near the top of the range. Borrowers who clean up denial workflows, document medical necessity proactively, and maintain low days-to-bill metrics produce measurably better availability.

Payor Concentration and Eligibility Filters

Healthcare ABL lenders apply concentration limits the same way commercial ABL lenders do, but the math is different because so few payors dominate the receivables base. Medicare alone often represents thirty to fifty percent of receivables for hospitals and post-acute providers. Lenders generally accept higher concentration on government payors than on commercial payors, because the credit risk on Medicare and Medicaid is the federal or state government rather than a commercial counterparty. Caps in the seventy to one hundred percent range on government payors are not unusual.

Commercial payor concentrations are different. Most lenders cap any single commercial payor at fifteen to thirty percent of the eligible borrowing base. Self-pay and patient-responsibility receivables are typically excluded entirely, given the dramatically lower collection rates. Workers compensation and personal injury claims are sometimes accepted at low advance rates with significant aging cutoffs.

Specialty Healthcare Sub-Sectors

Borrowing base mechanics vary meaningfully across healthcare sub-sectors. Specialty pharmacies and infusion providers often have stronger collection rates and better-defined contractual allowances, which supports higher advance rates. Behavioral health providers historically had higher denial rates and more complex authorization workflows, though parity rules have improved the picture. Home health agencies face Medicare prospective payment rules that change the cash conversion timing. Diagnostic labs deal with high commercial payor fragmentation. Each sub-sector has lenders that specialize in it -- and lenders that will quote it but not really understand it.

Equipment and Real Estate as Supplemental Collateral

For many healthcare borrowers, accounts receivable alone do not produce enough availability. Equipment and real estate are commonly added as supplemental collateral. Diagnostic imaging equipment, surgical equipment, lab analyzers, and treatment systems are appraised on a net orderly liquidation value basis, with advance rates typically running sixty to seventy-five percent of NOLV. Real estate -- owned hospital buildings, surgery centers, medical office buildings -- is appraised and advanced against at fifty to seventy percent of value.

Combining AR, equipment, and real estate into a single facility produces a meaningfully larger commitment than AR alone. The trade-off is appraisal cost, longer closing timeline, and additional collateral perfection work. For larger healthcare borrowers, the combined-collateral structure is the norm rather than the exception.

What Borrowers Need to Have Ready

Healthcare ABL deals get to commitment faster when the borrower brings the right data to the table. The standard package includes a payor-mix-segmented AR aging covering at least the last twelve months, a contractual allowance schedule by major payor, a denial and takeback history, a cash receipts roll showing actual collections by service month, equipment lists with model and age data for major assets, and a current rent roll if real estate is part of the collateral package. Providers who maintain this data in their revenue cycle management systems can produce it quickly. Providers who do not will spend the first four to six weeks of the deal building the data the lender needs.

The deeper points covered in our ABL credit package guide apply equally to healthcare deals, with the healthcare-specific addition of payor enrollment documentation, provider credentialing, and Medicare/Medicaid compliance history. A clean OIG exclusion check and a recent CIA disclosure (if applicable) accelerate diligence materially.

Lender Selection: This Sector Rewards Specialization

The list of lenders that genuinely understand healthcare ABL is shorter than the list of lenders that will quote it. The mechanics described above -- DACAs, contractual allowance calculations, payor concentration math, denial reserve methodology -- require credit, audit, and operations teams that have done it before. A generalist lender that quotes a healthcare deal will often back off late in the diligence process or land on terms that do not actually produce usable availability.

Borrowers who place healthcare ABL deals through specialists get better terms, faster closings, and post-closing workouts that do not blow up at the first denial spike or payor audit. Our guide to choosing the right ABL lender covers how we map sector specialization, and healthcare is one of the sectors where the specialization gap is widest.

Why DCE

We place ABL facilities for hospitals, physician practice management groups, surgery centers, diagnostic labs, behavioral health providers, home health agencies, specialty pharmacies, and the operating companies inside healthcare-focused private equity portfolios. We understand DACAs, contractual allowance methodology, payor concentration math, and the specific lender desks that have actual healthcare ABL teams. We know which lenders will accept seventy percent Medicare concentration and which will not. We know where the dilution reserves get negotiated and where the appraisal cost gets paid.

Don Clarke has been advising on asset-based lending since 1986 and has trained the senior underwriters at most major healthcare ABL lenders on this exact discipline. That is the difference between a deal that closes on workable terms and a deal that limps along until the next field exam blows up the borrowing base.

We do not consult. We execute.